Log in to save to my catalogue

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell t...

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4471913

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

About this item

Full title

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

Publisher

England: BioMed Central Ltd

Journal title

BMC hematology, 2015-06, Vol.15 (1), p.8-8, Article 8

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Valacyclovir has been used for prophylaxis against cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT). We investigated the efficacy and safety of high-dose Valacyclovir as pre-emptive therapy in patients with CMV antigenemia after HSCT.
In a retrospective single center study of 61 patients, we compared the rates...

Alternative Titles

Full title

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4471913

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4471913

Other Identifiers

ISSN

2052-1839

E-ISSN

2052-1839

DOI

10.1186/s12878-015-0028-2

How to access this item